CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 424B7 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 8-K/A Event Executive or director change
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 300,000 shares at an average $9.10 ($2,729,332)
- 4 Open-market sale President, CEO and Director sold 300,000 shares at an average $9.10 ($2,729,332)
- 424B7 Offering Prospectus
- EFFECT Other Notice of Effectiveness
Page 19 of 26 · 506 filings